LRRK2突变帕金森病外显率与发病年龄的全基因组关联研究
该研究对LRRK2突变携带者(776例病例和1103例末次评估非病例)进行了首个外显率和发病年龄的全基因组关联研究,采用Cox比例风险模型和线性混合模型。发现12号染色体CORO1C内含子变异rs77395454与外显率全基因组显著相关,且基于公开数据的多基因风险评分可显著预测外显率但不预测发病年龄。
要点
- CORO1C内含子变异rs77395454与LRRK2突变外显率全基因组显著相关。
- 多基因风险评分可预测LRRK2突变携带者的外显率,但不预测发病年龄。
- 3号染色体区域在外显率和发病年龄模型中均呈提示性关联。
核心结论
- CORO1C内或附近变异可能修饰LRRK2突变的外显率。
- 常见帕金森病相关变异 collectively 增加LRRK2突变的外显率。
研究设计与样本
- 首个针对LRRK2突变携带者外显率和发病年龄的全基因组关联研究,纳入776例病例和1103例末次评估非病例。
- 使用Cox比例风险模型识别外显率修饰因子,线性混合模型识别发病年龄修饰因子。
- 评估基于已发表帕金森病全基因组关联研究的 polygenic risk score 对外显率和发病年龄变异的解释能力。
主要发现
- 12号染色体CORO1C内含子区域变异rs77395454达到全基因组显著性(p值=2.5E-08,beta=1.27,SE=0.23,风险等位基因:C)。
- LRRK2与CORO1C的共免疫沉淀分析支持两种蛋白之间存在相互作用。
- 3号染色体一个既往报道的帕金森病易感性连锁峰区域在两个模型中均显示提示性关联(外显率顶级变异p值=1.1E-07;发病年龄顶级变异p值=9.3E-07)。
- 基于公开帕金森病汇总统计数据的多基因风险评分是外显率的显著预测因子,但不是发病年龄的预测因子。
临床怎么用
- 对于LRRK2突变携带者,可考虑整合CORO1C变异和多基因风险评分信息以辅助评估外显风险。
- 多基因风险评分目前不适用于预测LRRK2突变携带者的发病年龄。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study was to search for genes/variants that modify the effect of LRRK2 mutations in terms of penetrance and age-at-onset of Parkinson's disease. METHODS: We performed the first genomewide association study of penetrance and age-at-onset of Parkinson's disease in LRRK2 mutation carriers (776 cases and 1,103 non-cases at their last evaluation). Cox proportional hazard models and linear mixed models were used to identify modifiers of penetrance and age-at-onset of LRRK2 mutations, respectively. We also investigated whether a polygenic risk score derived from a published genomewide association study of Parkinson's disease was able to explain variability in penetrance and age-at-onset in LRRK2 mutation carriers. RESULTS: A variant located in the intronic region of CORO1C on chromosome 12 (rs77395454; p value = 2.5E-08, beta = 1.27, SE = 0.23, risk allele: C) met genomewide significance for the penetrance model. Co-immunoprecipitation analyses of LRRK2 and CORO1C supported an interaction between these 2 proteins. A region on chromosome 3, within a previously reported linkage peak for Parkinson's disease susceptibility, showed suggestive associations in both models (penetrance top variant: p value = 1.1E-07; age-at-onset top variant: p value = 9.3E-07). A polygenic risk score derived from publicly available Parkinson's disease summary statistics was a significant predictor of penetrance, but not of age-at-onset. INTERPRETATION: This study suggests that variants within or near CORO1C may modify the penetrance of LRRK2 mutations. In addition, common Parkinson's disease associated variants collectively increase the penetrance of LRRK2 mutations. ANN NEUROL 2021;90:82-94.
引用
- Lai D, Alipanahi B, Fontanillas P, et al. Genomewide Association Studies of LRRK2 Modifiers of Parkinson's Disease. Ann Neurol. 2021. PMID: 33938021. doi:10.1002/ana.26094
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。